BCV
CYTK icon

Banque Cantonale Vaudoise’s Cytokinetics CYTK Stock Holding History

Banque Cantonale Vaudoise’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-968
Closed -$81K – 1008
2023
Q4 		$81K Hold
968
– – ﹤0.01% 719
2023
Q3 		$29K Hold
968
– – ﹤0.01% 1026
2023
Q2 		$32K Sell
968
-50
-5% -$1.85K ﹤0.01% 1025
2023
Q1 		$36K Hold
1,018
– – ﹤0.01% 1002
2022
Q4 		$47K Sell
1,018
-127
-11% -$5.46K ﹤0.01% 967
2022
Q3 		$55K Buy
1,145
+148
+15% +$7.12K ﹤0.01% 970
2022
Q2 		$39K Sell
997
-467
-32% -$18.8K ﹤0.01% 1048
2022
Q1 		$54K Hold
1,464
– – ﹤0.01% 1030
2021
Q4 		$67K Buy
+1,464
New +$56.5K ﹤0.01% 1022

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Banque Cantonale Vaudoise's CYTK Position: Q1 2024 in Review

Banque Cantonale Vaudoise sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 968 shares — an estimated $81K sold.

Banque Cantonale Vaudoise first reported a position in CYTK in Q4 2021 and held it in 9 quarters. The position peaked at $81K in Q4 2023. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Banque Cantonale Vaudoise reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 968 Cytokinetics shares in Q1 2024, an estimated $81K.
  • Banque Cantonale Vaudoise first reported a position in Cytokinetics in Q4 2021 and held it in 9 quarters.
  • Banque Cantonale Vaudoise's Cytokinetics position peaked at $81K in Q4 2023.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2024, filed 10 Apr 2024.